Congressional Delays Persist as Robert F. Kennedy Jr. Postpones Senate Testimony for Fifth Month

Senate health committee members are expressing growing frustration as Robert F. Kennedy Jr. continues to delay his highly anticipated testimony regarding his views on public health and vaccine safety. Despite an invitation issued nearly half a year ago by Senator Bill Cassidy, the hearing has been repeatedly stalled due to scheduling conflicts and ongoing negotiations over the scope of the questioning.

By: AXL Media

Published: Feb 14, 2026, 11:01 AM EST

Source: This report is a comprehensive analysis based on data originally documented by NBC News

A Prolonged Standoff in the Senate

On February 13, 2026, it was confirmed that Robert F. Kennedy Jr. has yet to appear before the Senate Health, Education, Labor, and Pensions (HELP) Committee, five months after the initial request was made. Senator Bill Cassidy (R-Louisiana), who serves as the ranking member of the committee, first invited Kennedy to testify in September 2025 following Kennedy’s appointment to a high profile federal advisory role. The objective was to provide a public forum for Kennedy to address concerns regarding his long standing skepticism of traditional medical practices and immunization programs.

While both parties initially signaled a willingness to proceed, the logistics of the appearance have become a source of political friction. Committee sources indicate that Kennedy’s team has requested specific conditions for the hearing, including a minimum time allotment for opening statements and a limit on the topics covered during the cross examination phase.

Bipartisan Frustration and Health Concerns

The continued absence of Kennedy from the Senate floor has drawn criticism from both sides of the aisle. Democratic lawmakers argue that the delay allows Kennedy to influence national health policy from his advisory position without facing the standard congressional oversight. Senator Bernie Sanders, the committee chair, has previously stated that any individual wielding significant influence over the nation’s health agencies must be prepared to answer tough questions under oath.

Public health advocates have also voiced concerns that the lack of a formal hearing leaves many of Kennedy’s controversial claims unchallenged in a legislative setting. The topics expected to be covered in the testimony include: